Public Company News
Forrester's Singapore CX Index: For The First Time, Insurers Surpassed Banks In Delivering Better Customer Experiences
SINGAPORE, Sept. 20, 2021 /PRNewswire/ -- According to Forrester's
2021-09-20 13:17
13460
Citibank Singapore is no. 1 bank for customer experience in independent research firm report
SINGAPORE, Sept. 20, 2021 /PRNewswire/ -- Citibank was ranked as the top bank for the first time in an annualSingapore customer experience study by global research and advisory firm Forrester released today. The bank took top spot in the Forrester Singapore 2021 Customer Experience Index (CX Inde...
2021-09-20 13:14
14040
Appealing Data of CARsgen Therapeutics' CAR-T (CT041) in Advanced Gastric Cancer Presented at ESMO
SHANGHAI, Sept. 19, 2021 /PRNewswire/ -- On September 19, 2021, CARsgen Therapeutics (stock code: 2171.HK) disclosed the latest progress of the investigator-initiated trial (IIT) of Claudin18.2 (CLDN18.2) CAR-T (CT041) for the treatment of digestive system tumors. Results of this trial have been ...
2021-09-20 08:24
10346
Dubber acquires world class AI technology company Notiv
MELBOURNE, Australia, Sept. 20, 2021 /PRNewswire/ -- Dubber Corporation Limited
(ASX: DUB) (Dubber) announces today that it has acquiredBrisbane, Australia
based technology group Notiv (https://www.notiv.com)
2021-09-20 08:04
12794
Illumina reaffirms commitment to the National Project of Bio Big Data in Korea
MELBOURNE, Australia, Sept. 20, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that the National Project of Bio Big Data in Korea has selected Illumina technology for the second pilot project in their effort to work towards establishing a national digital library on health and...
2021-09-20 07:00
6483
Cambium Networks 60 GHz cnWave Technology Enables Pentanet to Rapidly Build a Multi-Gigabit Fixed Wireless Network Serving Perth, Australia
Innovative broadband service provider delivers multi-gigabit speeds to the network edge ROLLING MEADOWS, Ill., Sept. 20, 2021 /PRNewswire/ -- Cambium Networks (NASDAQ: CMBM), a leading global provider of wireless networking solutions, today announced thatPentanet is building neXus, a multi-gigab...
2021-09-20 06:30
13268
CStone presents preliminary results from a phase Ib study of the anti-CTLA-4 monoclonal antibody (mAb) CS1002 in combination with the anti-PD-1 mAb CS1003 in patients with advanced solid tumors at ESMO 2021
SUZHOU, China, Sept. 19, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative cancer immunotherapies and precision medicines, today announced the preliminary results from t...
2021-09-19 09:00
4820
2021 CSCO | Henlius will Release Four Oral Presentations of Two Upcoming Commercial Products: Novel anti-PD-1 mAb Serplulimab and Bevacizumab Biosimilar
SHANGHAI, Sept. 18, 2021 /PRNewswire/ -- The 24th Annual Meeting of Chinese Society of Clinical Oncology (CSCO) will be held online and in-person from 25th to 29th September 2021. In this meeting, Henlius will release 4 study results of 2 products to be commercialized, the novel anti-PD-1 mAb ser...
2021-09-18 20:00
12566
XCMG Excavator Logs Cumulative Production and Sales of 200,000 Units
XUZHOU, China, Sept. 18, 2021 /PRNewswire/ -- The XCMG Excavator Machinery Business Department of XCMG has manufactured a total of 200,000 units of excavators since its establishment in 2008, the fastest OEM brand to reach this level of sales across the engineering manufacturing industry. The 200...
2021-09-18 18:33
14105
Lufax Joins FTSE ESG Low Carbon Select Indexes
SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- Lufax Holding Ltd ("Lufax" or the "Company") (NYSE: LU), a leading technology-empowered personal financial services platform inChina, today announced that the Company will be added to the following FTSE ESG Low Carbon Select Indexes, following FTSE Russell...
2021-09-18 10:00
22218
Innovent Releases Interim Analysis Results of Sintilimab plus Chemotherapy for the First-Line Treatment of Esophageal Squamous Cell Carcinoma in the Phase 3 ORIENT-15 Study at ESMO Congress 2021
SAN FRANCISCO and SUZHOU, China, Sept. 18, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dis...
2021-09-18 08:00
8103
Innovent Releases Interim Analysis Results of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma in the Phase 3 ORIENT-16 Study at ESMO Congress 2021
SAN FRANCISCO and SUZHOU, China, Sept. 18, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...
2021-09-18 08:00
15914
Zoomlion Breaks Yet Another Record for High-End Manufacturing, Exports China's Largest Tonnage Crawler Crane
CHANGSHA, China, Sept. 17, 2021 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion"; 1157.HK) exported the ZCC32000 crawler crane toTurkey on September 16, setting a new record for the largest tonnage crane exported fromChina, fully demonstrating the growing brand i...
2021-09-17 22:05
10359
ZTE wins largest share in bid section 4 of China Mobile's high-end router centralized procurement
SHENZHEN, China, Sept. 17, 2021 /PRNewswire/ -- ZTE Corporation (0763. HK / 000063.SZ), a major international provider of telecommunications, enterprise, and consumer technology solutions for the mobile internet, today announced that it has secured the share of 50% in section 4 of China Mobile's ...
2021-09-17 21:28
8765
Hysan Development Acquires Premium Commercial Project in Jing'an District for RMB3.5 billion
* Prime location with similar character to Hysan's Lee Gardens in Hong Kong * Important step of Hysan's long-term planning and ambition in Shanghai HONG KONG, Sept. 17, 2021 /PRNewswire/ -- Hysan Development Company Limited ("Hysan" or "the Group",Hong Kong stock code: 00014) is pleased to ann...
2021-09-17 21:19
6203
Baidu-Backed DeepWay Unveils Smart New Energy Heavy-Duty Truck to Automate Road Freight
BEIJING, Sept. 17, 2021 /PRNewswire/ -- DeepWay, a Baidu-backed company, today unveiled Xingtu, a smart new energy heavy-duty truck with a computing power of more than 500 TOPS and ultra-long-distance sensing capabilities of more than 1 kilometer. This announcement marks Baidu's entry into the US...
2021-09-17 21:09
5606
MINISO Group Files Annual Report on Form 20-F for Fiscal Year 2021
GUANGZHOU, China, Sept. 17, 2021 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO) ("MINISO", "MINISO Group" or the "Company"), a fast-growing global value retailer offering a variety of design-led lifestyle products, today filed with the U.S. Securities and Exchange Commission its annual...
2021-09-17 20:45
18379
The NDA of Henlius Novel Anti-PD-1 mAb Serplulimab for First-Line Treatment of sqNSCLC Accepted by China's NMPA, Phase 3 MRCT Met its Primary Endpoint
SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the New Drug Application (NDA) of Serplulimab Injection (HLX10), a novel anti-PD-1 monoclonal antibody (mAb) independently developed by the company, in combination with carboplatin and albumin-bound ...
2021-09-17 20:00
4918
InnoCare and Keymed Jointly Announce Approval of Clinical Trial of CD20xCD3 Bispecific Antibody CM355
BEIJING, Sept. 17, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969) and Keymed Biosciences (HKEX: 02162) jointly announced today that the Investigational New Drug (IND) of CM355, a CD20xCD3 bispecific antibody developed by a joint venture between the two companies called Tiannuojiancheng Pharm...
2021-09-17 20:00
5900
RYB Education, Inc. Reports Second Quarter 2021 Financial Results
BEIJING, Sept. 17, 2021 /PRNewswire/ -- RYB Education, Inc. ("RYB" or the "Company") (NYSE: RYB), a leading early childhood education service provider in China, today announced its unaudited financial results for the second quarter of 2021. Second Quarter 2021 Operational and Financial Summary ...
2021-09-17 20:00
18051
Week's Top Stories
Most Reposted
Most Read
Asia Pacific Travellers Seek Familiarity, Practicality, Flexibility Amid Shifting Global Dynamics: Visa Report
2026-06-16 10:00
7324
All Eyes on Korea: CSOP KOSPI 200 ETF (3121.HK) to List on HKEX Tomorrow
2026-06-17 21:17
5869
